Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2016

Conditions
Acute Respiratory FailureTreatment With Noninvasive Positive Pressure Ventilation
Interventions
DEVICE

High-flow humidified nasal oxygen delivery system

During breaks from NIV oxygen will be provided through the Optiflow with FiO2 and flow-rate titrated to maintain the oxygen saturation (SpO2) above 90%.

DEVICE

Standard oxygen therapy

During breaks from NIV oxygen will be provided by standard nasal cannula or mask to maintain the SpO2 above 90%.

Trial Locations (2)

02111

Intensive Care Unit and Intermediate Care Unit, Tufts Medical Center, Boston

01890

Intensive Care Unit, Winchester Hospital, Winchester

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Tufts Medical Center

OTHER

NCT01925534 - Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation | Biotech Hunter | Biotech Hunter